SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-026620
Filing Date
2018-11-05
Accepted
2018-11-05 07:02:09
Documents
55
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nerv-10q_20180930.htm 10-Q 1040428
2 EX-31.1 nerv-ex311_7.htm EX-31.1 16944
3 EX-31.2 nerv-ex312_9.htm EX-31.2 16748
4 EX-32.1 nerv-ex321_6.htm EX-32.1 9544
  Complete submission text file 0001564590-18-026620.txt   4694794

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nerv-20180930.xml EX-101.INS 914350
6 XBRL TAXONOMY EXTENSION SCHEMA nerv-20180930.xsd EX-101.SCH 42115
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nerv-20180930_cal.xml EX-101.CAL 34615
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nerv-20180930_def.xml EX-101.DEF 172147
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20180930_lab.xml EX-101.LAB 355437
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20180930_pre.xml EX-101.PRE 282693
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36517 | Film No.: 181158711
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences